Ivenix

Amesbury, United States Founded: 2001 • Age: 25 yrs Acquired By Fresenius Kabi
Infusion management systems are developed with wireless web-based architecture.

About Ivenix

Ivenix is a Healthcare company based in Amesbury (United States) founded in 2001, and was acquired by Fresenius Kabi in March 2022. It operates as an infusion management systems are developed with wireless web-based architecture. Ivenix has raised $159.97 million across 9 funding rounds from investors including Eight Roads Ventures, 6 Dimensions Capital and F-Prime Capital. The company has 60 employees. Its chief executive is Stuart Randle. Ivenix offers products and services including Ivenix Infusion System and Large Volume Pump. Its focus areas include Life Sciences, Hospital Equipment, Critical Care and Infusion Systems. Its legal entity is IVENIX, INC. Its competitors include Assurex Health, 410 Medical, Hospira, Hygieia and Belmont Medical Technologies and 3 more; 6 of its 8 listed competitors have raised funding.

Company details

Ivenix was founded in 2001 in Amesbury, United States, within the healthcare technology sector. Infusion management systems are provided, integrating information systems into infusion devices. Wireless, web-based architecture is used to connect pumps attached to patients. Remote dashboards are accessed by nurses, pharmacists, and clinical engineers for decision support. Pump data across organizations is analyzed for quality and efficiency improvements. FDA review remains pending.

Key Metrics

Products & Services of Ivenix

Ivenix offers a comprehensive portfolio of products and services, including Ivenix Infusion System and Large Volume Pump.

Ivenix Infusion System
Medical Device

Delivers accurate fluid control for intravenous administration

Large Volume Pump
Infusion Equipment

Enables precise flow measurement in clinical environments

Funding Insights of Ivenix

Ivenix has successfully raised a total of $159.97M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $50 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $159.97M
  • Total Rounds 9
  • Last Round Series E β€” $50M
  • First Round $2.3M

    (Jul 2009)

  • Investors Count 7

All 9 funding rounds of Ivenix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2017$50MSeries E––
Sep 2015$42.3MSeries D–6 Dimensions Capital
Aug 2011$25MSeries C––
Aug 2011$19.83MSeries B––
–
Feb 2011$499,999Debt – Conventional––
–
Feb 2011$499,999Debt – Conventional––
–
Oct 2010$10.27MSeries A––
–
Mar 2010$10.27MSeries A––
–
Jul 2009$2.3MSeed––
–
Valuation history

8 investors in total: 8 institutional.

Investors in Ivenix

Ivenix has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Eight Roads Ventures, 6 Dimensions Capital and F-Prime Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
–6dimensionscapital.comPudong, China
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
–fprimecapital.com-
Life science & tech focused VC firm investing in early stage companies in the US
–cardinalpartners.comPrinceton, United States
A venture capital firm focused on life science investments.
2002scpvitalife.comTel-Aviv, Israel
Venture capital investment and global platform support for startups.
2008eightroads.comLondon, United Kingdom
-
–rockportventure.com-
Delivers financial advisory services including planning, analysis, and wealth management.
2012easterlycapital.comBeverly, United States
Healthcare solutions in pharmaceuticals, nutrition, MedTech, and biopharmaceuticals.
1999fresenius-kabi.com-
Premium access

Investor details for Ivenix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ivenix

1 people are tracked at Ivenix (1 in leadership); the tracked headcount is 60.

NameRoleGroup
Stuart Randle
CEO & PresidentLeadership
Premium access

Complete people profiles for Ivenix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ivenix

4 dated milestones of Ivenix across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ivenix is founded.
  2. Funding First funding round of $2.3M.
  3. Funding Latest funding round, Series E, of $50.0M.
  4. Exit Acquired by Fresenius Kabi.

Competitors of Ivenix

Ivenix has 8 listed competitors in our database, 6 of them funded. They include Assurex Health, 410 Medical, Hospira, Hygieia and Belmont Medical Technologies, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
assurexhealth.com2006Mason, United States$84.47M390
Personalized medication for neuropsychiatric conditions is guided by pharmacogenomics.
410medical.com2012Durham, United States$65.98M–
Rapid infusion systems are provided for critically ill patients.
hospira.com2004Lake, United States–2,658
Injectable drugs, infusion technologies, and biosimilars are manufactured and supplied.
hygieia.com2007Ann Arbor, United States$8.79M17
Insulin dosage guidance for diabetes is provided via handheld devices.
belmontmedtech.com1980Billerica, United States–212
Fluid management and critical care medical devices are developed.
medeye.com2010–$12.01M–
Medication safety platform for hospitals is provided online by MedEye.
vitagene.com2014San Francisco, United States$5.8M8
Personalized supplement recommendations are generated from genomic and health data.
insight-rx.com2015San Francisco, United States$13.25M23
Precision dosing is optimized via machine learning and patient data.
Premium access

Detailed competitors of Ivenix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ivenix

The website of Ivenix (ivenix.com) receives about 2.4K visits a month.

  • Monthly visits
    2.4K

    ▲ 2% vs previous month

Similar websites

Websites whose visitors overlap most with Ivenix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
omnicell.com
100%
95.2K#366,441View details

Top companies in Clinical IT & Data Platforms

10 companies that operate in the same segment as Ivenix (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 716.99 M–1,832
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M–1,746
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 473.73 M–3,902
App-based health insurance is offered to individuals and businesses.
2016Paris, Ile de France, FranceUSD 863.12 M–1,606
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M992
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M–2,470
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ivenix

Premium access

Complete news archive for Ivenix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ivenix

Ivenix was founded in 2001 and raised its 1st funding round 8 years after it was founded.

Ivenix is headquartered in Amesbury, United States. It is registered at Amesbury, Massachusetts, United States.

Stuart Randle is the current CEO of Ivenix.

Ivenix is a funded company, having raised a total of $159.97M across 9 funding rounds to date. The company's 1st funding round was a Seed of $2.3M, raised on Jul 2009.

Ivenix has 60 employees.

Ivenix was founded in 2001 in Amesbury, United States, within the healthcare technology sector. Infusion management systems are provided, integrating information systems into infusion devices. Wireless, web-based architecture is used to connect pumps attached to patients. Remote dashboards are accessed by nurses, pharmacists, and clinical engineers for decision support. Pump data across organizations is analyzed for quality and efficiency improvements. FDA review remains pending.

Ivenix's top competitors include 410 Medical, Belmont Medical Technologies and Hospira.

Ivenix offers Ivenix Infusion System and Large Volume Pump.

Ivenix has 8 investors. Key investors include Eight Roads Ventures, 6 Dimensions Capital, F-Prime Capital, Cardinal Partners, and Easterly Capital.

Ivenix operates through Ivenix, Inc..

Yes. Ivenix was acquired by Fresenius Kabi in March 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available